Estudios originales
Published on 29 de diciembre de 2022 | http://doi.org/10.5867/medwave.2022.11.2562
Factors related to mortality in patients with stage 5 chronic kidney disease on dialysis with COVID-19: An exploratory case series analysis
Back to article
Factors related to mortality among patients with stage-5 chronic kidney disease on dialysis with COVID-19, laboratory factors (n=105).
Variable | Alive | Deceased | Risk relative (95% CI) | ||
n | % | n | % | ||
≤ 7 | 21 | 39.6 | 32 | 60.4 | Ref. |
> 7 | 17 | 32.7 | 35 | 67.3 | 1.21 (0.58 to 3.21) |
> 1000 | 32 | 94.1 | 2 | 5.9 | Ref |
≤ 1000 | 52 | 73.2 | 19 | 26.8 | 1.28 (1.95 to 4.89) |
≤ 11 000 | 48 | 96 | 2 | 4 | Ref |
> 11 000 | 34 | 61.8 | 21 | 38.2 | 1.55 (2.28 to 38.02) |
> 150 000 | 70 | 78.7 | 19 | 21.3 | Ref. |
≤ 150 000 | 14 | 87.5 | 2 | 12.5 | 0.89 (0.15 to 2.27) |
≤ 1,5 | 49 | 89.1 | 6 | 10.9 | Ref |
> 1,5 | 35 | 70 | 15 | 30 | 1.27 (1.15 to 6.53) |
≤ 1000 | 57 | 89.1 | 7 | 10.9 | Ref |
> 1000 | 27 | 65.9 | 14 | 34.1 | 1.35 (1.34 to 7.08) |
≤ 10 | 58 | 98.3 | 1 | 1.7 | Ref |
> 10 | 26 | 56.5 | 20 | 43.5 | 1.74 (1.57 to 20.13) |
≤ 400 | 52 | 98.1 | 1 | 1.9 | Ref |
> 400 | 32 | 61.5 | 20 | 38.5 | 1.59 (2.83 to 36.40) |
> 20 | 56 | 93.3 | 4 | 6.7 | Ref |
≤ 20 | 28 | 62.2 | 17 | 37.8 | 1.51 (1.24 to 15.68) |
≤ 5.5 | 53 | 76.8 | 16 | 23.2 | Ref. |
> 5.5 | 31 | 86.1 | 5 | 13.9 | 0.89 (0.24 to 1.51) |
< 40 | 25 | 80.7 | 6 | 19.3 | Ref. |
≥ 40 | 59 | 79.7 | 15 | 20.3 | 1.05 (0.45 to 2.45) |
< 40 | 16 | 76.2 | 5 | 23.8 | Ref. |
≥ 40 | 68 | 80.9 | 16 | 19.1 | 0.94 (0.33 to 1.93) |
> 150 | 79 | 97.5 | 2 | 2.5 | Ref |
≤ 150 | 5 | 20.8 | 19 | 79.2 | 4.68 (4.03 to 27.95) |
ALT, alanine aminotransferase. AST, aspartate aminotransferase. CRP, C-protein reactive. IU/L, international units per liter. LDH, Lactate dehydrogenase. PaO2/FiO2, Arterial Oxygen Pressure / Inspired Oxygen Fraction. cell/uL, cells per microliter. g/dL, grams per deciliter. mg/dL, milligrams per deciliter. mmHg, millimeters of mercury. mmol/L, millimoles per liter. HCO3, bicarbonate. Ref., Reference.